0.1.0 - ci-build
RarecareFHIRIG - Local Development build (v0.1.0). See the Directory of published versions
This page provides a list of the FHIR artifacts defined as part of this implementation guide.
These define constraints on FHIR resources for systems conforming to this implementation guide
| Disease Management Plan |
The PlanDefinition for a rare conditions refers to PlanDefinitions of other diseases, i.e. Shwachman-Diamond Syndrome is typically associated with Neutropenia. The disease plan refers to medication, lab tests and other items for management of the disease. |
| Questionnaire for functioning |
The FunctioningQuestionnaire is a questionnaire for patients with rare conditions. It captures aspects of their functioning relevant to their specific disease. |
| Lab Test Activity |
A Disease is associated with Symptoms, which may be abnormal lab values, represented by LOINC codes. |
| Lab Test Observation |
A Disease is associated with Symptoms, which may be abnormal lab values, represented by LOINC codes. |
| Medication Administration Activity |
A Disease is treated with medication. |
| Questionnaire for participation |
The ParticipationQuestionnaire is a questionnaire for patients with rare conditions. It captures aspects of their activities and participation relevant to their specific disease. |
| Rare Condition Management Plan |
The PlanDefinition for a rare conditions refers to PlanDefinitions of other diseases, i.e. Shwachman-Diamond Syndrome is typically associated with Neutropenia. A code from Orphanet is required. |
These define sets of codes used by systems conforming to this implementation guide
| ICF b codes: BODY FUNCTIONS |
All codes from ICF B subhierarchy: BODY FUNCTIONS |
| ICF d codes: ACTIVITIES AND PARTICIPATION |
All codes from ICF D subhierarchy: ACTIVITIES AND PARTICIPATION |
These are example instances that show what data produced and consumed by systems conforming with this implementation guide might look like
| Calcidiol (25-hydroxy-Vitamin D3) in serum/plasma ActivityDefinition |
Calcidiol (25-hydroxy-Vitamin D3) in serum/plasma |
| Neutrophils in blood ActivityDefinition |
Neutrophils in blood measurement |
| Pancreatine |
Pancreatine |
| Retinol (Vitamin A) in serum/plasma ActivityDefinition |
Retinol (Vitamin A) in serum/plasma |
| Functioning Questionnaire for Development Disability | |
| Calcidiol (25-hydroxy-Vitamin D3) in serum/plasma ActivityDefinition | |
| Neutrophils in blood ObservationDefinition | |
| Retinol (Vitamin A) in serum/plasma ActivityDefinition | |
| Ontwikkelingsstoornis PlanDefinition |
Neutropenia management plan. |
| Neutropenia PlanDefinition |
Neutropenia management plan. |
| Pancreas Insufficiëntie PlanDefinition |
Pancreas Insufficiëntie management plan. |
| Shwachman Diamond Syndrome PlanDefinition |
Shwachman Diamond Syndrome management plan. |
| Participation and Activities Questionnaire for Shwachman Diamond Syndrome |